drugset / Trial / NCT04191447

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

NCT04191447

Phase 3 Unknown 134 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Flamboyant 200/12 association in adults with asthma.

Timeline

Start
2022-07-22
Primary completion
2023-07
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 400 unknown Inhaled
Subject Flamboyant Unknown 12 unknown Inhaled
Subject Flamboyant Unknown 200 unknown Inhaled
Comparator Formoterol Other / unclassified 12 unknown Inhaled

Indications